Clinical application of letrozole in ovulation induction for women with polycystic ovary syndrome

Hui-qin ZHANG,He-xia XIA,Wei ZHANG

DOI: https://doi.org/10.3969/j.issn.1673-5293.2009.04.030

2009-01-01

Abstract:Objective To investigate influences of letrozole on endometrial growth of infertile women with polycystic ovary syndrome (PCOS) in ovulation induction. Methods 60 infertile women with PCOS were divided into letrozole group(n=40) and clomiphene citrate (CC) group(n=20). 40 patients in letrozole group received 5mg per day of letrozole and 20 patients in CC group received 50mg per day of CC from day 5 to day 9 of menstrual cycle respectively. Ultrasonography was used to monitor follicular development and endometrial thickness of patients in the two groups. And serum level of estradiol (E2) of all patients was detected on day 5 and day 10 of menstrual cycle and hCG injection day. When diameter of the largest follicle was ≥18mm, the patient was given 10000 U of hCG intramuscularly to induce ovulation. The serum level of E2 and endometrial thickness of all patients in the two groups were compared. Results The level of E2 of patients in the letrozole group was significantly lower than CC group on day 10 of menstrual cycle and hCG injection day respectively (t=-15.6500, -15.0039 respectively,both P<0.05). Furthermore, in the letrozole group, the serum level of E2 on 10 day of menstrual cycle of the patients was lower than that on day 5 of menstrual cycle. In endometrial thickness of patients on day 10 of menstrual cycle there was no significant difference between the two groups, but the endometria of patients in the letrozole group (8.06±2.13mm) were significantly thicker than CC group (6.43±1.18mm) on the hCG injection day(t=3.1903,P=0.002). Conclusion Letrozole could decrease serum level of E2 and inhibit growth of endometrium of infertile women with PCOS in ovulation induction, however, its inhibitory role for endometrial growth is weaker than CC.